神经炎症
中枢神经系统
医学
小胶质细胞
胶质纤维酸性蛋白
紧密连接
内皮干细胞
血管生成
血管内皮生长因子
细胞生物学
病理
星形胶质增生
少突胶质细胞
神经胶质
封堵器
作者
Azeb Tadesse Argaw,Linnéa Asp,Jingya Zhang,Kristina Navrazhina,Trinh Pham,John N. Mariani,Sean S. Mahase,Dipankar J. Dutta,Jeremy Seto,Elisabeth G. Kramer,Napoleone Ferrara,Michael V. Sofroniew,Gareth R. John
摘要
In inflammatory CNS conditions such as multiple sclerosis (MS), current options to treat clinical relapse are limited, and more selective agents are needed. Disruption of the blood-brain barrier (BBB) is an early feature of lesion formation that correlates with clinical exacerbation, leading to edema, excitotoxicity, and entry of serum proteins and inflammatory cells. Here, we identify astrocytic expression of VEGF-A as a key driver of BBB permeability in mice. Inactivation of astrocytic Vegfa expression reduced BBB breakdown, decreased lymphocyte infiltration and neuropathology in inflammatory and demyelinating lesions, and reduced paralysis in a mouse model of MS. Knockdown studies in CNS endothelium indicated activation of the downstream effector eNOS as the principal mechanism underlying the effects of VEGF-A on the BBB. Systemic administration of the selective eNOS inhibitor cavtratin in mice abrogated VEGF-A-induced BBB disruption and pathology and protected against neurologic deficit in the MS model system. Collectively, these data identify blockade of VEGF-A signaling as a protective strategy to treat inflammatory CNS disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI